[144] Sight Sciences, Inc. SEC Filing

Rhea-AI Filing Summary

Sight Sciences, Inc. (SGHT) Form 144 notifies of a proposed sale of 20,000 common shares through Fidelity Brokerage Services with an aggregate market value of $73,400. The notice lists the approximate sale date as 09/19/2025 and reports 52,367,359 shares outstanding, showing the planned sale relative to total equity.

The shares were originally acquired by the holder via restricted stock vesting on 10/16/2024 as compensation. The filing also discloses recent sales by the same person, Matthew Link: 4,889 shares on 07/02/2025 for $20,036.59, 10,000 shares on 09/12/2025 for $35,227.21, and 15,990 shares on 09/16/2025 for $55,291.81. The filer certifies no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider sale disclosure; transaction appears compliance-driven and not materially large versus outstanding shares.

The filing reports a proposed sale of 20,000 common shares valued at $73,400 and shows prior insider sales totaling 30,879 shares in the recent period. Compared with 52.37 million shares outstanding, the disclosed sales represent a de minimis percentage of the float. Acquisition via restricted stock vesting indicates these were compensation shares rather than open-market purchases. For investors, this is a standard Rule 144 compliance notice documenting insider disposition and provenance of shares; it provides transparency but not new operational or financial information about the issuer.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; signature representation maintains regulatory compliance.

The filer certifies absence of undisclosed material adverse information and notes the shares were acquired through restricted stock vesting. The sequence of disclosures and multiple sale dates shows adherence to reporting obligations. This filing is governance-positive in that it documents insider transactions and includes provenance and payment nature (compensation), aiding transparency. There are no indications in the notice of related-party issues or unusual transfer mechanisms.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	20000	73400.00	52367359	09/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/16/2024	Restricted Stock Vesting	Issuer			20000	10/16/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Matthew Link 4040 Campbell Ave, Suite 100 Menlo Park CA 94025	Common	07/02/2025	4889	20036.59
Matthew Link 4040 Campbell Ave, Suite 100 Menlo Park CA 94025	Common	09/12/2025	10000	35227.21
Matthew Link 4040 Campbell Ave, Suite 100 Menlo Park CA 94025	Common	09/16/2025	15990	55291.81

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)